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Resistance to infection with Trypanosoma cruzi, the causative agent of
Chagas' disease, may be mediated by cellular immunity (1). Lesions of the
disease are characterized by infiltration with lymphocytes and macrophages (2),
and patients have delayed skin hypersensitivity to antigens of T. cruzi (3). In
experimental animals, immunity can be transferred with spleen cells from
immune animals (4) but not with immune serum (1). That macrophages play a
major role in the defense mechanism to T. cruzi is suggested by studies in vivo
indicating that organisms are destroyed in the macrophages of immune mice
while they survive and reproduce in macrophages of nonimmune mice (5).
The present study describes the resistance to T. cruzi ofcultured macrophages
from mice immune to the homologous agent, and also of macrophages from mice
immunized with BCG or Listeria. However, BCG- or Listeria-immunized mice
were not protected against challenge in vivo with T. cruzi.
Materials and Methods
Animals. Inbred C3H/StCrl strain female mice, purchased from Charles River Breeding
Laboratories, North Wilmington, Mass., weighed 14-16 gwhen used.
Organisms and Immunizations.
￿
The House 510 strain (H510)' of T. cruzi from Costa Rica (6),
supplied by Dr. F. A. Neva, National Institute of Allergy and Infectious Disease, was maintained by
serial blood passage in C3H mice and in Novy, MacNeal and Nicolle's biphasic medium (NNN).
Before use this strain wascultured in F29liquid medium (7)at 35°C for48 to 72 hat whichtime 5-15%
of the organisms were trypomastigotes and the remainder largely epimastigotes. Parasites were
washed twice with Hanks' solution and counted in a Neubauer hemocytometer.
Mice were immunized against T. cruzi by intraperitoneal injection of 105 H510 T. cruzi. After 60
days, when the infection became chronic, these immune mice were either challenged with T. cruzi or
they provided the source of macrophages for in vitro cultures and the source of immune serum.
Listeria monocytogenes was obtained from Dr. J. R. David, Robert B. Brigham Hospital, Boston,
Mass. Mice were immunized by a sublethal intravenous injection of 5 x 10' bacteria 6 days before
challenge with T. cruzi or collection of macrophages (8). Mice were immunized with BCG
(Glaxo-strain BCG Vaccine, EliLilly & Co., Indianapolis, Ind.) by injecting them with 4 x 105 to 9 x
*This investigation was supported in part by Training Grant AI-00046 from the National
Institutes of Health, U. S. Public Health Service, and was carried out in partial fulfillment of the
requirements for the Degree of Doctor of Science in the field of Tropical Public Health .
'Abbreviations used in this paper: FCS, fetal calf serum; H510, House 510strain of T. cruzi from
Costa Rica ; NNN, Novy, MacNeiland Nicolle's biphasic medium; PE cells, peritoneal exudatecells.
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105 mycobacteria intraperitoneally 18 days and again 3 days before challenge with T. cruzi or
collection of macrophages.
Challenge of Mice with T. cruzi.
￿
Mice immunized with H510 T. cruzi, BCG, or Listeria were
challenged by two methods. For sublethal challenge, mice were injected with 5 x 105 H510 culture
forms grown in F29 as above . The course of the infection in control and challenged mice was then
assessed by quantifying parasitemia in blood samples lysed with isotonic ammonium chloride
solution (9) . For lethal challenge, mice were injected intraperitoneally with 10' blood-stream
trypomastigotes of a Colombian strain of T. cruzi (10) . This strain was maintained by serial blood
passage in Charles River CD-1 mice from which inoculum for challenging immunizedC3H mice was
obtained on the 12th day of infection.
Immune and Control Sera. Sera collected from T. cruzi-immune mice, and control sera from
normal mice, were inactivated at 56°C for 30 min before use.
Preparation of Peritoneal Macrophage Cultures.
￿
Mice were exsanguinated and 3-4 mt of Hanks'
solution (containing 10 U of heparin per ml) were injected intraperitoneally. Peritoneal exudate,
withdrawn with a Pasteur pipet, was pooled from several mice. Peritoneal exudate cells (PE cells)
were centrifuged (250 g) and were resuspended in Medium 199 (Microbiological Associates,
Baltimore, Md.) containing 15% fetal calfserum (FCS),and antibiotics (100 U penicillin and 100 kg of
streptomycin per ml) . PE cells were counted in ahemocytometer andthe suspension was adjusted to
desired concentration. About 45-50% of the PE cells were macrophages as assessed in Giemsa-stained
smears. To assay resistance to T. cruzi, 1 x 108 to 2 x 108 PE cells, suspended in 0.75 ml medium,
were added to tissue culture chamber-slides (4-chamber, Lab Tek Products, Div. Miles Laboratories,
Naperville, Ill.). To assay resistance to Listeria, 5 x 108 PE cells, suspended in 2.0 ml of medium
without antibiotics, were plated in 35-mm diameter plastic tissue culture dishes (Falcon Plastics,
Div. of BioQuest, Oxnard, Calif.). Cultures were incubated at 37°C in 5% CO, and air. Nonadherent
cells were removed with twochanges of medium 1-2 h after cultures were prepared . Thecultures were
used 18-24 h later.
Assay of Macrophage Resistance to T. cruzi.
￿
Macrophage cultures were exposed to 0.75 x 108 to
2 .0 x 108 H510 T. cruzi grown in F29. After 24 h of exposure, extracellular parasites were removed
with two changes of medium. At specified intervals thereafter replicate cultures were fixed with
Zenker's solution and stained with buffered Giemsa. Macrophage density was indexed by counting
cells in 10 ocular grids (7 mm x 7 mm), using a 40x objective and a calibrated mechanical stage to
locate identical coordinates in each chamber. Intact parasites found in 250 or 500 macrophages were
counted, using a 100x objective, and the percent of infected cells and the mean number of T. cruzi
per 100 macrophages were calculated.
Assay ofMacrophage Resistance to Listeria.
￿
Intracellular bacteriostasis of Listeria was assessed
by modifying the method of Fowles et al. (11). The freeze-thaw lysis with distilled water was repeated
three times to release intracellular bacteria for counting, and the amount of macrophage cell-protein
was then estimated. Viability of Listeria was not significantly reduced by the modified procedure.
Results
In Vitro Culture of Macrophages from T. cruzi-Immune Mice.
￿
Within 15-30
min of incubation in culture, macrophages from mice immunized with T. cruzi
("immune" macrophages) spread rapidly and circumferentially on glass (Fig.
1B). By contrast, macrophages from normal mice ("normal" macrophages) began
spreading only after 3 h, and did not spread fully until the next day. Immune
macrophages were also more adherent to glass in the culture chambers. Thus, to
obtain equivalent numbers of normal and immune macrophages in the cultures
(i .e ., varying less than 10%), twice as many normal PE cells (2.0 x 106) as
immune PE cells (1 .0 x 106) were plated . Nearly 100% of adherent PE cells
remaining in cultures after 24 h were macrophages as judged by their morphology
and uptake of India ink or starch particles. Although peritoneal exudates from
immune mice contained free trypomastigotes at the time of collection, macro-
phages cultured overnight from these mice were parasite-free .RODNEY HOFF
FIG. 1 .
￿
Macrophages from normal andT . cruzi-immune mice:(A) Normal macrophages after
30-min incubation . (B) Immune macrophage after 30-min incubation . (C) Normal macro-
phages after 24-h exposure to T . cruzi . (D) Immune macrophage after 24-h exposure to T.
cruzi. (E) Growth of T. cruzi in normal macrophages after 72-h incubation . (F) Absence of
parasites in immune macrophages after 72-h incubation .
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Challenge of Normal and Immune Macrophage Cultures with T. cruzi.
￿
Inoc-
ulating a relatively large number of parasites caused a high loss of normal
macrophages. However, when the inocula contained less than five parasites per
adherent macrophage, fewer cells (less than 10%) were lost from the monolayer.
The number of organisms taken up by macrophages then depended on exposure
time. Using an inoculum containing two parasites per adherent cell, the number
of organisms taken up and the percentage of infected macrophages increased
gradually during the first 24-h exposure period . At the end of the exposure period,
intracellular parasites in normal macrophages appeared morphologically intact,
whereas many organisms in immune macrophages appeared to be degenerating.
In the assay, to assess cellular uptake, intracellular parasites were counted
after the 24-h exposure period, and to assess survival or reproduction they were
counted after 48 and 72 h. Results were consistent in five replicate experiments,
and representative findings are shown in Fig. 2. Uptake of parasites differed little
in replicate cultures within an experiment but varied from one experiment to
another. After 48 h the number of intracellular organisms and the percent of
infected cells declined markedly in immune macrophages and less so in normal
macrophages. Thereafter, in normal macrophages the surviving parasites began
reproducing as amastigotes and after 72 h some cells contained up to 40
organisms (Fig . 1 E) . At this time, the intracellular amastigotes began transform-
ing into trypomastigotes, and host-cell lysis ensued . In contrast, the number of
intracellular parasites in immune macrophages remained low, and from 48 to 72
h only occasional lightly parasitized cells were found (Fig. 1 F) . Because
disappearance of T. cruzi in immune macrophages could be attributed to initial
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FiG. 2. Resistance to T. cruzi by macrophages from specifically immune mice. Normal
macrophages (N) and immune macrophages (Tc-1) were exposed to 1 x 108 organisms. Other
cultures of immune macrophages (Tc-2) were exposed to 2 x 108 organisms. Values are shown
as means f SE of triplicate cultures .uptake of fewer parasites, cultures of immune macrophages were exposed to
heavier inocula (Fig. 2, Tc-2). More parasites were then taken up by the immune
macrophages than by controls. Nevertheless, again after 48 and 72 h the number
of intracellular T. cruzi declined markedly in the immune cells.
Time-Course Development of Macrophage Resistance to T. cruzi.
￿
In vitro
resistance to T. cruzi by macrophages from infected mice first appeared in those
collected 21 days after infection, and persisted for 70 days or more (Fig. 3).
Macrophages collected 7 days postinfection did not spread rapidly and were not
resistant to challenge in the in vitro assay. Although some macrophages ( <10%)
appeared activated at 14 days postinfection, the cultured cells were not resistant
to challenge in vitro.
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FIG. 3.
￿
Time-course development of macrophage resistance to T. cruzi. 30 mice were injected
with T. cruzi. Starting at 7 days postinfection, and at weekly intervals thereafter, parasitemia
was measured in 5 mice and their PE cells were harvested and assayed for resistance to T. cruzi
in vitro. Macrophages from infected mice were judged resistant when intracellular T. cruzi
decreased to low numbers, in contrast to their increase in normal macrophages.
Specificity of In Vitro Macrophage Resistance to T. cruzi. The in vitro
specificity of activated macrophages was explored by challenging activated
macrophages derived from mice infected with BCG or Listeria. Macrophages
from these mice spread rapidly on glass. BCG-activated macrophages showed the
same degree of resistance to T. cruzi as did T. cruzi-activated macrophages. As
with specifically activated macrophages, BCG-activated macrophages took up
fewer parasites than normal macrophages. In the experiment summarized in Fig.
4, greater uptake was achieved by doubling the inoculum and by substituting
normal mouse serum for FCS in the exposure medium. Even with greater initial
uptake ofparasites, the BCG-activated macrophages were able to contain the in-
fection.304
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FIG. 4.
￿
Nonspecific in vitro resistance to T. cruzi by macrophages from mice immunizedwith
BCG. Control macrophages (N) andBCG-activatedmacrophages (BCG-1) were exposed to 108
parasites suspended in medium containing 15% normal mouse serum. Other cultures of
BCG-activated macrophages (BCG-2) were exposed to 2 x 108 parasites in the same medium.
Values shown are means f SE of six replicate cultures. Note that BCG-2-activated
macrophages displayed enhanced resistance to T. cruzi even though they took up more
parasites initially than did normal controls.
Macrophages activated by Listeria infection were less resistant to T. cruzi
challenge than were macrophages activated by T. cruzi or BCG infection. After
48 h incubation in some experiments, surviving parasites in the Listeria-ac-
tivated macrophages appeared to reproduce.
Enhanced Macrophage Resistance to Listeria by T. cruzi-Activated
Macrophages. This experiment was designed to confirmthat Listeria-activated
macrophages used in the previous experiment were indeed resistant to Listeria,
and to explore whether T. cruzi-activated macrophageswere resistanttoListeria.
Both the Listeria- and the T. cruzi-activated macrophages were significantly
more bacteriostatic than were normal macrophages (Fig. 5).
Effect of Cytophilic Antibody on In Vitro Infection of Macrophages with T.
cruzi. Cultures ofnormal macrophages and of macrophages from T. cruzi- and
BCG-immune mice were washed twice with medium and incubated for 1 h with
0.5 ml of medium containing 15% normal or immune mouse serum to bind
cytophilic antibodies . After incubation the macrophage cultures were washed
again, and infected with T. cruzi suspended in medium with 15% A-Gamma
globulin FCS instead of FCS. After a 24-h exposure, control macrophages
preincubated with normal mouse serum took up nearly all parasites inoculated .
However, T. cruzi- and BCG-activated macrophages, also preincubated witha 0
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FIG. 5 . Enhanced resistance to Listeria in vitro by macrophages from T. cruzi- (Tc) and
Listeria- (Lm) immune mice. Cultures were exposed for 10 min to 2.7 x 10' bacteria. The
number of intracellular bacteria was assessed immediately after exposure and 2, 6, and 16 h
later. Values shown are means t SE of triplicate cultures. After 16 h both T. cruzi- and
Listeria-activated macrophages contained significantly fewer bacteria than did normal
macrophages (P < 0.001).
normal serum, took up less than half as many T. cruzi as did controls, and many
extracellular parasites were left in the supernatant medium . In contrast, when
preincubated with immune serum, the activated macrophages took up nearly all
the inoculum and contained as many intracellular parasites as did control
macrophages (Fig. 6). Cytophilic antibody did not, however, render normal
macrophages resistant to infection. In other experiments, direct opsonization of
the inoculum with immune serum caused agglutination, thereby affecting the
distribution of intracellular infection in the monolayer and making evaluation
difficult .
Challenge of Listeria- and BCG-Immune Mice with T. cruzi.
￿
Since nonspe-
cifically activated macrophages resist infection in vitro with T. cruzi, mice
immunized with BCG or Listeria were challenged with T. cruzi to determine
whether either immunization was protective in vivo. Parasitemia in BCG-
immune mice or in Listeria-immune mice, when challenged with H510 T. cruzi,
followed a course similar to that in control mice; however, in mice immunized
and challenged with T. cruzi, parasitemia was low (Fig. 7) . In another
experiment, opsonizing the inoculum with immune serum failed to protect
control and BCG-immune mice .
Since challenge with H510 was nonlethal, immune mice were also challenged
with the lethal Colombian strain. BCG immunization failed to prevent or
significantly delay mortality in mice challenged with this strain, while mice306
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FIG. 6 .
￿
Effect of immune mouseserumon the uptake ofT. cruziby macrophages during 24 h
of exposure to 1 .5 x 10° parasites . Light bars indicate uptake by macrophages preincubated
with normal mouse serum; dark bars indicate uptake by macrophages preincubated with
immune mouse serum. Values are means t SE of six replicate cultures.
immunized by infection with H510 T. cruzi survived challenge with the lethal
strain (Fig . 8) .
Discussion
The results indicate that peritoneal macrophages from mice with induced
resistance to T. cruzi have an enhanced capacity to kill T. cruzi in vitro.
Macrophage resistance, which developed in about 3wk after mice were infected
with T. cruzi, also occurred in macrophages from BCG-immunized mice . In
contrast to these findings in vitro, immunizing mice with BCG or Listeria did not
protect them against challenge with T. cruzi .
Controversy exists concerning the ability of T. cruzi to reproduce in macro-
phage cultures . Uptake in vitro and subsequent reproduction of T. cruzi in
macrophages has been reported by others (12-14). Dvorak et al. (15), on the
other hand, observed no division of T. cruzi after infection of mouse peritoneal
macrophages with either epimastigotes or trypomastigotes . These authors point
out that parasite survival in multiply-infected macrophages might misleadingly
be interpreted as parasite reproduction . In the present studies, dividing
intracellular amastigotes were observed after 48 h. Although multiple infections
were common, the number of intracellular parasites per cell increased while the
density of macrophages remained constant, strongly suggesting parasite multi-
plication . Besides the increase in numbers, the appearance of extracellular
trypomastigotes in the supernatant medium after 72 h suggests the completion of
the intracellular reproductive cycle as described by Behbehani (12) .0 0
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FIG. 7 .
￿
Challenge of BCG-, Listeria- and T. cruzi-immune mice with T. cruzi. Mice were
injected intraperitoneally with 5 x 105 culture forms of T. cruzi. The course of parasitemia in
normal mice ("-"), BCG-immune mice ("-"), Listeria-immune mice (O---O, Listeria-
hyperimmune mice (A---0), and T. cruzi-immune mice ("-") is shown. Mean parasitema
of five mice per group is shown. Note that only specifically immune mice were resistant to T.
cruzi challenge even though peritoneal macrophages from BCG- and Listeria-immune mice
were resistant to in vitro infection.
In the present in vitro studies, macrophages from specifically immunized mice
killed intracellular T. cruzi while the organism survived and grew in normal
macrophages. This finding is consistent with the in vivo findings of Taliaferro
and Pizzi (5) who observed destruction of virulent blood forms of T. cruzi in the
macrophages of immune C3H mice . Likewise, in vitro killing of other intracellu-
lar protozoa by macrophages from specifically immune hosts has been reported
(16-18).
After 24 h exposure, fewer T. cruziwere present in BCG- and T. cruzi-immune
macrophages than in normal macrophages. This finding parallels that noted by
Miller and Twohy (18) using Leishmania donouani. These authors suggest that
decreased susceptibility of immune macrophages to infection may represent a
mechanism of resistance to Leishmania. Our results show that resistance to T.
cruzi penetration was nonspecific since both T. cruzi- and BCG-immune
macrophages, exposed to equivalent inocula, took up fewer organisms than did
control macrophages. Other possible explanations for the observed difference in
uptake of T. cruzi may be their early intracellular death and digestion by308
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￿
Cumulative mortality among normal and BCG- or T. cruzi-immune C3H/HcJ mice
(40 per group) challenged with 10' blood-stream forms of Columbian-strain T. cruzi. Graph
key: normal (N, "-"), BCG-immune (BCG, "-"), and T. cruzi-immune (Tc, "-") mice.
immune macrophages, or rapid reproduction of the parasites in normal macro-
phages.
Efforts were made to ensure that the number of normal macrophages in
experimental cultures equalled or exceeded that of immune macrophages, and to
ensure that immune macrophages took up equal or greater numbers of T. cruzi
than did control macrophages. Thus, enhanced killing could be attributed to
properties of immune macrophages rather than to a decreased parasite uptake or
to greater macrophage numbers.
Enhanced killing of T. cruzi by macrophages derived from T. cruzi-infected
mice appeared during the 3rd week of infection when parasitemia was still
increasing. This corresponds in time to the first successful transfer of immunity
with spleen cells in rats infected with T. cruzi (4). Thus, there is evidence in vivo
and in vitro that cellular immunity may function early in the natural history of
the infection to protect the host; this contrastswith the much later appearance of
partially protective humoral antibody demonstrated using serum passively
transferred from rats (19) .
Mackaness (20) showed that macrophages become activated by specific
immunological mechanisms, but once activated couldkill organismsunrelated to
the original immunogen. Nonspecific bacterial resistance by activated macro-
phages has been produced by infection with Toxoplasma (21) . In the present
studies, macrophages from T. cruzi-immune mice were nonspecifically resistant
to infection with Listeria in vitro, and macrophages from BCG-immune mice
were nonspecifically resistant to infection with T. cruzi in vitro. Tanowitz et al.
(13) in similar experiments observed that macrophages from BCG-immunized
mice were more resistant to destruction by T. cruzi than were normal macro-
phages . The above contrasts with recent findings of others who did not find
comparable nonspecific resistance to Toxoplasma, Besnoitia, and Leishmania bynonspecifically activated macrophages (17, 22). These authors suggest that
macrophage resistance to these intracellular protozoa has specific qualities and is
dependent on the host-parasite combination.
The incorporation of specific antibody greatly increased the uptake of T. cruzi
by macrophages but did not interfere with their intracellular replication in
normal macrophages. Similar interactions of antibody, parasites, and macro-
phages have been reported by others (18, 23, 24).
The surprising finding of this study is that BCG-immune mice, whose
peritoneal macrophages strongly resisted T. cruzi infection in vitro, were not
protected against in vivo challenge, i.e., there was no difference in parasitemiaor
mortality between control and BCG-immunized mice challenged with sublethal
or lethal injections of T. cruzi. Mice immunized and boosted with BCG are
resistant to Listeria challenge for more than 8 wk (25), a period longer than that
of an acute T. cruzi infection in mice. Hanson 2 was also unable to demonstrate
protection in BCG-immunized mice challenged with T. cruzi. The above results
suggest that nonspecific activation of macrophages alone is insufficient com-
pletely to protect mice against T. cruzi even when the parasites are opsonized.
Even if all infected parasites were to be taken up by activated macrophages,
some organisms must survive and initiate infection.
Obviously, therefore, in T. cruzi-immune mice other cellular or humoral
factors must function, in addition to nonspecifically activated macrophages, to
produce the specific immunity demonstrated in Figs . 7 and 8. It has been shown,
for example, that specifically sensitized lymphocytes are required for arming
macrophages to kill Toxoplasma and Besnoitia (17) . T. cruzi invades various
connective tissue cells and there may escape intracellular destruction by
activated macrophages. It may be that specifically sensitized lymphocytes are
required to call forth and focus the macrophage reaction on the parasite, or that
specifically sensitized lymphocytes or their products in combination with
antibody are required for an immunity to T. cruzi. This study points outthe need
to combine in vitro and in vivo experiments when investigating mechanisms of
immunity to intracellular parasites.
Summary
Peritoneal macrophages from T. cruzi-immune mice were resistant to infection
in vitro with culture forms of the parasite . Macrophage resistance appeared in
infected mice about 21 days postinfection when parasitemia was still rising.
Resistance in vitro was nonspecific since macrophages from BCG-immune mice
were resistant to T. cruzi, and since macrophages from T. cruzi-immune mice
were resistant to infection in vitro with Listeria. Despite the findings in vitro,
mice immunized with BCG or Listeria were not resistant to challenge with T.
cruzi even when the parasites were opsonized.
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